Johns Hopkins Carey Business School Professor and Vice Dean for Faculty and Research Valerie Suslow, joined by research colleague Margaret Levenstein of the University of Michigan, examines the impact of relaxed regulations against corporate collusion during the COVID-19 pandemic.
While scientists around the world search for a coronavirus vaccine, an equivalent effort should be made to develop drugs that would mitigate the virus’s effects on patients, says Johns Hopkins Carey Business School Senior Lecturer Bonnie Robeson, who previously served as a principal investigator in drug discovery and development at the National Cancer Institute.
Alessandro Rebucci, an economist and associate professor at Johns Hopkins Carey Business School, has analyzed the impact of current health interventions to stop COVID-19 as well as lessons learned from previous economic crises. He offers important insights for policymakers.
Johns Hopkins Carey Business School Assistant Professor Haiyang Yang finds in a new study that people who perceived themselves as knowledgeable about COVID-19 – regardless of the actual amount of their knowledge – experienced more happiness during the outbreak than those who didn’t perceive themselves as informed about COVID-19.
Johns Hopkins Carey Business School Assistant Professor Erik Helzer, an expert in conflict management and ethical leadership, examines the motivations behind stockpiling by shoppers during the pandemic.
Johns Hopkins Carey Business School Associate Professor Jim Kyung-Soo Liew leads a team that has created an online map showing the locations of coronavirus testing stations throughout the United States.
When a large pharmaceutical company experiences a drug trial failure and then tries to refill its pipeline by licensing a product created by another firm, such a “rushed innovation” is less likely to bring a product to market than one developed under normal, less hurried conditions. That’s because the hastily drawn licensing agreement between the two organizations leads to friction that drags development work to a halt.
Supriya Munshaw, a senior lecturer at Johns Hopkins Carey Business School, offers insights on the likely time frame for a coronavirus vaccine, the steps involved in developing one, the most promising candidates currently in the labs of biotech companies, and why, years after the MERS and SARS outbreaks, a coronavirus vaccine still has not been produced.
When Italians self-isolating during the COVID-19 outbreak were presented with a hypothetical situation in which orders to remain at home would be for shorter periods than they had expected, they were pleasantly surprised and said they would be more willing to stay in isolation. But people negatively surprised to hear that the hypothetical extensions of the orders would be for longer than they had anticipated said they would be less willing to maintain or increase their isolation.
Consumers are clearing store shelves. Some observers call it “panic buying.” But a Johns Hopkins University expert on consumer behavior, while acknowledging that panic is an element of the phenomenon, says stockpiling can be seen as a rational approach to shopping during a pandemic.
Johns Hopkins Carey Business School Professor Kathleen Sutcliffe, a leading expert in organization theory, gives low marks to public and private entities for how they’ve responded to the coronavirus threat and outbreak.
Johns Hopkins Carey Business School Associate Professor Alessandro Rebucci offers his interpretation of what COVID-19 means for the markets in the near term and long term.
Johns Hopkins Carey Business School professors Goker Aydin and Tinglong Dai of Carey Business School discuss how COVID-19 is impacting business supply chains and operations.
When substance use disorder patients were tested for both HIV and hepatitis C virus at the same time and given the results within 20 minutes, they were far more likely a month later to indicate they had received results, compared with patients who were referred for testing services.
Steven D. Cohen, an associate professor at the Johns Hopkins Carey Business School, is well known for helping leaders communicate with confidence, influence, and authority. Cohen studies the communication behaviors of effective leaders, with a particular focus on executive presence.
The W. P. Carey Foundation, whose generosity launched Johns Hopkins Carey Business School, has made a $25 million commitment to the school to recruit renowned faculty, enhance academic programs, and help launch student careers. The gift will be matched with commitments from Johns Hopkins University and contributions from other donors for a total of $50 million.
The highest-earning nonprofit hospitals in the United States provided less charity care to patients than lower-earning hospitals did, relative to the facilities’ respective profits, according to a new study.
A new study by Carey Business School researchers notes that some expert medical diagnosticians may order fewer patient tests as a way to indicate a high level of competence to their peers. They do so despite an increase in diagnostic techniques that can assess patient condition more accurately than former methods.
Medical errors remain as vexing a problem, according to Bloomberg Distinguished Professor Kathleen Sutcliffe of Johns Hopkins University. She discusses the issue in her new book Still Not Safe: Patient Safety and the Middle-Managing of American Medicine, co-authored with Robert Wears.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right